PTPRK and central nervous system cancer: Moreover, PTPRK mutations altered the inhibitory effect of wild type PTPRK on EGFR and β-catenin signaling pathways which correlate with observed alterations in PTPRK mediated suppressive effects on growth and migration of glioma cells.